Catalyst Wire Dossier Catalyst Wire Dossier

LIPO-102

· Neothetics, Inc.
Drug timelines are a Plus or Pro feature.

5 regulatory and trial events tracked for LIPO-102, covering 2015-03-06 to 2015-03-26. Get the full timeline:

Most recent: Clinical Trial Update: A Dose-ranging, Study of the Safety and Efficacy of Subcutaneous Injections of LIPO-102 Compared With Placebo for the Reduction of Abdominal Subcutaneous Adiposity [Phase 2]

See pricing